{
    "clinical_study": {
        "@rank": "68999", 
        "arm_group": {
            "arm_group_label": "Newly diagnosed type 2 patients", 
            "arm_group_type": "Other", 
            "description": "The initial assessment of daily insulin dose."
        }, 
        "brief_summary": {
            "textblock": "To investigate the daily dose of insulin in newly diagnosed Chinese type 2 diabetic patients\n      who use the continuous subcutaneous insulin infusion (CSII) as the initial therapy."
        }, 
        "brief_title": "The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes.", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All participants with type 2 diabetes, diagnosed by World Health Organization criteria,\n        were recruited from outpatient of the Endocrinology Department in Shanghai Renji Hospital.\n\n        Exclusion Criteria:\n\n        Patients who had a history of coronary heart disease, abnormal renal function, active\n        liver disease, chronic metabolic acidosis (including diabetic ketoacidosis), or severe\n        chronic gastrointestinal disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "65", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02143440", 
            "org_study_id": "2012273"
        }, 
        "intervention": {
            "arm_group_label": "Newly diagnosed type 2 patients", 
            "intervention_name": "The initial assessment of daily insulin dose.", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200127"
                }, 
                "name": "Renji Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "When the glucose level decreased to about 10 mmol/L", 
            "safety_issue": "No", 
            "time_frame": "72-96 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02143440"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "RenJi Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RenJi Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }
}